In accordance with previous reports, our results indicated that LAMC2 silencing inhibited lung cancer cell progression through reduced cell activity, increased apoptosis, arrest in G1 to S cell cycle progression, and diminished tumor growth in vivo. This evidence concerns the gene LAMC2 and lung carcinoma.